4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Seres Therapeutics, Inc. (MCRB) operates in the Biotechnology industry and is headquartered in Cambridge, United States with about 66 employees. Its market capitalization is roughly $52 million. In the fiscal year ended 2025-12-31, MCRB reported $1M in revenue and $6M in net income.
Seres Therapeutics, Inc., a clinical-stage company, focuses on developing biotherapeutics for serious diseases.
Interactive charts & full statements → Open the MCRB valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $1M | $0M | $0M | $0M | — |
| Gross Profit | ($6M) | ($4M) | $0M | $0M | — |
| Operating Income (EBIT) | ($94M) | ($121M) | ($195M) | ($180M) | — |
| Net Income | $6M | $0M | ($114M) | ($250M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $1M | $0M | $0M | $0M | — |
| Gross Profit | $0M | $0M | ($1M) | ($2M) | ($4M) | — |
| Operating Income (EBIT) | ($21M) | ($19M) | ($22M) | ($25M) | ($27M) | — |
| Net Income | ($20M) | ($15M) | $8M | ($20M) | $33M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $138M | $140M | $359M | $349M | — |
| Total Liabilities | $94M | $126M | $404M | $338M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive MCRB viewer.
About TickerBase · Data methodology & sources